INVO Fertility exchanges $1.34M convertible debenture for Series C-2 convertible preferred shares

INVO Fertility, Inc.

Five Narrow Lane LP exchanged its 7% convertible debenture due Feb 2026 for Series C-2 Preferred stock with $1,334,000 stated value.
Company issued 467 additional Series C-2 Preferred shares as part of the exchange consideration.
Debenture fully extinguished; total outstanding reduced by the exchanged amount.
Exchange executed under registration exemptions; no new cash proceeds raised.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

INVO Fertility, Inc. issued 467 additional shares of Series C-2 Preferred Stock of preferred stock to Five Narrow Lane LP for aggregated stated value of 1,334,000.

Security: preferred stock
Shares: 467 additional shares of Series C-2 Preferred Stock
Purchaser: Five Narrow Lane LP
Consideration: aggregated stated value of 1,334,000

Exact text from the filing

the Company and Five Narrow Lane LP, a Delaware limited partnership (“ FNL ”) entered into an agreement (the “ Exchange Agreement ”) pursuant to which FNL agreed to exchange a Second Amended and Restated Senior Secured Convertible Debenture Due February 11, 2026 (the “ Second Amended and Restated Debenture ”) held by FNL for receipt of shares of Series C-2 Convertible Preferred Stock (the “ Series C-2 Preferred Stock ”) with an aggregated stated value of 1,334,000. In consideration thereof, the Company agreed to issue 467 additional shares of Series C-2 Preferred Stock to FNL.

View on SEC.gov

25 equity issuances filed in the last 30 days. Browse all equity issuances →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-016076

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.